why choose us

First received: April 30, 2023

Clinical Trial: The Study of Envafolimab Combined With Concurrent Chemoradiotherapy In LS-SCLC

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Lung Neoplasms

Study Type: INTERVENTIONAL


Official Title: A Prospective, Two Cohort, Multicenter Phase II Clinical Study of Envafolimab Combined With Concurrent Chemoradiotherapy and Immune Maintenance Therapy For Limited Stage Small Cell Lung Cancer

Brief Summary: To evaluate the efficacy and safety of envafolimab combined with concurrent chemoradiotherapy in limited stage small cell lung cancer.

Read more